Leerink Swann Upgrades Allergan To Outperform

Analysts at Leerink Swann upgraded Allergan AGN from Market Perform to Outperform. The target price for Allergan is set to $184. Allergan shares have surged 64.59% over the past 52 weeks, while the S&P 500 index has gained 12.49% in the same period. Allergan's shares dropped 3.30% to close at $151.92 yesterday.